NEWS & PRESS
News
May 25, 2023
May 25, 2023
Global Business Reports Interview: CEO Michael Quirmbach Talks on 2023 Capex Investments in Oligonucleotides, Peptides & LNP Formulation
Global Business Reports Interview: CEO Michael Quirmbach Talks on 2023 Capex Investments in Oligonucleotides, Peptides & LNP Formulation
April 23, 2023
April 23, 2023
CordenPharma Opens Early Phase Drug Product Innovation Centre of Excellence with Bioavailability Enhancement Technologies.
CordenPharma Opens Early Phase Drug Product Innovation Centre of Excellence with Bioavailability Enhancement Technologies.
November 17, 2022
Nov 15, 2022
CPHI Online Interviews Dr. Michael Quirmbach at CPHI Frankfurt 2022.
CPHI Online Interviews Dr. Michael Quirmbach at CPHI Frankfurt 2022.
October 20, 2022
October 20, 2022
Chemistry Today interviews Dr. Brittany Hayes on Highly Potent CDMO manufacturing trends.
Chemistry Today interviews Dr. Brittany Hayes on Highly Potent CDMO manufacturing trends.
September 13, 2022
Sept 13, 2022
PHARMAnetwork Interviews Dr. Michael Quirmbach in 2022 CDMO CEO Visions & Strategies Issue.
PHARMAnetwork Interviews Dr. Michael Quirmbach in 2022 CDMO CEO Visions & Strategies Issue.
August 11, 2022
August 11, 2022
PMPS Article > Dr. Brittany Hayes discusses mini-tablet dose form development considerations for pediatric patients.
PMPS Article > Dr. Brittany Hayes discusses mini-tablet dose form development considerations for pediatric patients.
July 15, 2022
July 4, 2022
Manufacturing Chemist Article: Fabio Stevanon gives keys to cost-efficient sterile injectable manufacturing.
Manufacturing Chemist Article: Fabio Stevanon gives keys to cost-efficient sterile injectable manufacturing.
July 6, 2022
July 1, 2022
C&EN Article: Eiger & CordenPharma Bring Orphan Drug Zokinvy (Lonafarnib) for Rare Disease Progeria to Market
C&EN Article: Eiger & CordenPharma Bring Orphan Drug Zokinvy (Lonafarnib) for Rare Disease Progeria to Market
June 8, 2022
June 8, 2022
World Pharma Today Interview: Dr. Brittany Hayes talks trends & strategy of Oral Solid Dose (OSD) manufacturing.
World Pharma Today Interview: Dr. Brittany Hayes talks trends & strategy of Oral Solid Dose (OSD) manufacturing.
April 13, 2022
April 13, 2022
CordenPharma Receives Supplier Recognition Award from Esperion at DCAT Week 2022.
CordenPharma Receives Supplier Recognition Award from Esperion at DCAT Week 2022.
March 10, 2022
March 10, 2022
CordenPharma donates a combined €100,000 to support disaster relief efforts in the Ukraine.
CordenPharma donates a combined €100,000 to support disaster relief efforts in the Ukraine.
March 3, 2022
March 3, 2022
Global Business Reports Interview: CEO Michael Quirmbach Talks 2022 Expanded Footprint & Growth Strategy
Global Business Reports Interview: CEO Michael Quirmbach Talks 2022 Expanded Footprint & Growth Strategy
January 13, 2022
January 13, 2021
DCAT Value Chain Insights Interview: CEO Michael Quirmbach Talks Trends & Issues in the CDMO Sector for 2022.
DCAT Value Chain Insights Interview: CEO Michael Quirmbach Talks Trends & Issues in the CDMO Sector for 2022.
November 23, 2021
November 23, 2021
Interview with CordenPharma Chenôve, Yves Michon, Managing Director
Interview with CordenPharma Chenôve, Yves Michon, Managing Director